Enteric Campylobacteriosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-11-20
Clinical Trial Update: Efficacy of Rifaximin in Preventing Campylobacteriosis [Phase 2, Phase 3]
Clinical trial update on rifaximin for prevention of Campylobacteriosis shows completed Phase 2/3 study results; results posted in 2018.